Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Emerging Markets · Neuberger Berman Equity

Neuberger Emerging Markets Equity Fund Class R3 (NEMRX)

Ticker NEMRX · · Holdings as of May 31, 2026

Expense ratio
1.6%$160/yr per $10k
5-yr return
−1.0%annualized
1-yr return
+12.2%as of Dec 2024
Net assets
$234.6Mall share classes
Holdings
48

Bottom line

Is NEMRX a good fund? The bottom line

NEMRX is the Class R3 share class of Neuberger Emerging Markets Equity Fund, an actively managed emerging markets mutual fund from Neuberger Berman Equity.

Annual fees run 1.6% — about $160 a year on every $10,000 invested, more expensive than 87% of emerging markets funds we track.

It returned +12.2% over one year, −1.0% a year over five years, +2.2% a year over ten (as of Dec 31, 2024, per its prospectus).

With $235 million in net assets and 48 holdings, its largest position is State Street Global Advisors (4.6%) and the top 10 make up 33.7% of the portfolio.

What to watch

  • Expensive for its category (1.6%)
  • 5-year return in the bottom quarter of its category
  • 12b-1 marketing fee of 0.5% a year

Updated Nov 19, 2026

What NEMRX invests in

The Fund seeks long-term growth of capital.

To pursue its goal, the Fund normally invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in equity securities of issuers in emerging market countries. These include securities of companies (1) that are traded principally on a stock exchange or over-the-counter in emerging market countries, (2) that are organized under the laws of and/or have a principal office in emerging market countries, or (3) that derive 50% or more of their total revenues from, and/or have 50% or more of their total assets in, goods produced, sales made, profits generated or services performed in emerging market countries. The Fund considers emerging market countries to be countries included in the MSCI Emerging Markets Index. The Portfolio Managers use a bottom-up, research-driven securities selection approach focusing on businesses which they believe exhibit a…

From the fund's prospectus (filed Feb 10, 2026).

NEMRX performance

Fund calendar-year total returns, 2015–2024 2015: −12.1%; 2016: +8.5%; 2017: +40.6%; 2018: −17.8%; 2019: +18.2%; 2020: +12.6%; 2021: −4.0%; 2022: −24.3%; 2023: +4.0%; 2024: +12.2% −12% 2015 +9% 2016 +41% 2017 −18% 2018 +18% 2019 +13% 2020 −4% 2021 −24% 2022 +4% 2023 +12% 2024
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
NEMRX+12.2%−1.0%+2.2%
Emerging Markets median+27.8%+3.0%+7.6%

Source: Fund prospectus, as of Dec 31, 2024

Full NEMRX performance history →

What NEMRX costs

On a $10,000 investment, NEMRX's 1.6% expense ratio costs about $160 a year. The prospectus estimates $2,185 in total costs over 10 years (assuming 5% annual returns). The median emerging markets fund charges 1.02%.

See the full NEMRX fee table →

NEMRX top 10 holdings

#Holding% of fund
1State Street Global Advisors4.62%
2Richter Gedeon Nyrt4.30%
3China Resources Land Ltd3.60%
4Kasikornbank PCL3.55%
5Orion Corp/Republic of Korea3.21%
6PDD Holdings Inc3.20%
7Vale SA3.03%
8Petroleo Brasileiro SA - Petrobras2.87%
9Baidu Inc2.67%
10Ternium SA2.65%

Source: SEC Form N-PORT, period ended May 31, 2026

The top 10 make up 33.7% of the fund. See all top 25 holdings and asset mix →

Alternatives to NEMRX

More funds like NEMRX →

NEMRX FAQ

What is the expense ratio of NEMRX?
NEMRX's expense ratio is 1.6%, which works out to about $160 a year for every $10,000 invested. The prospectus estimates total costs of $2,185 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is NEMRX a good investment?
It depends on your goals, but the data points to: expensive for its category (1.6%); 5-year return in the bottom quarter of its category; 12b-1 marketing fee of 0.5% a year. This is general information, not personalized advice.
What does NEMRX hold?
NEMRX's largest holdings are State Street Global Advisors (4.6%), Richter Gedeon Nyrt (4.3%), China Resources Land Ltd (3.6%), Kasikornbank PCL (3.5%), Orion Corp/Republic of Korea (3.2%). It holds 48 positions in total as of May 31, 2026 (SEC Form N-PORT).
What is NEMRX's 5-year return?
NEMRX returned −1.0% a year over the five years ending Dec 31, 2024, and +2.2% a year over ten years. Past performance does not guarantee future results.
Who manages NEMRX?
NEMRX is offered by Neuberger Berman Equity through Neuberger Berman Equity Funds.